Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in Virginia
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Virginia
| Provider | Medicare | Services |
|---|---|---|
| Smith, Michael MD | $124.42 | 52 |
| Weigle, Jeffrey M.D. | $128.19 | 44 |
| Kelleher-Linkonis, Nicole MD | $124.90 | 39 |
| Gabriel, Ryan MD | $118.29 | 37 |
| Carpenter, Sarah MD | $118.78 | 35 |
| Halista, Kevin M.D. | $460.97 | 31 |
| Patel, Zeal MD | $121.88 | 28 |
Virginia Pricing in Context
In Virginia, CPT code 19081 (Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth) carries an average Medicare payment of $217.17 — 3% above the national benchmark of $210.47. 230 providers across the state submitted claims for this procedure in 2023, performing 2.0K total services. Individual payments in VA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Virginia is $1,422.70, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Virginia sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Skin/Integumentary Surgery procedures, the estimated commercial insurance price in Virginia lands near $613.31, with self-pay cash prices typically around $600.33. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth cost in Virginia?
The average Medicare payment for Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in Virginia is $217.17, which is 3% above the national average of $210.47. Providers in VA typically bill $1,422.70 for this procedure.
What does Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth cost with insurance in Virginia?
With commercial insurance in Virginia, Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth costs an estimated $613.31. Without insurance, the estimated cash price is $600.33. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in Virginia?
230 providers in Virginia billed Medicare for Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth in 2023, performing 2.0K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth cheaper in Virginia than the national average?
No — Biopsy Of Breast And Placement Of Locating Device Using X-Ray With Needle, First Growth costs 3% above the national average in Virginia. The state average Medicare payment is $217.17 compared to $210.47 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.